bcbs glp 1 coverage Why Blue Cross Blue Shield is rolling back of GLP-1 weight loss drugs in Massachusetts bcbs michigan glp-1 Coverage of

Description

By subscribing, you accept our Terms & Privacy Policy.

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 17.99 / 30 days cancel any time Subscribe to this journal Receive 12 digital issues and online access to articles 99.00 per year only 8.25 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

North America dominates the market landscape, supported by favorable reimbursement policies, advanced healthcare infrastructure, and high treatment adoption rates

Romariz LM, de Melo AAC, Finnegan E, Mesquita Y, Janovsky C

Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) show substantial efficacy in regulating blood glucose levels and lipid metabolism, initially as an effective treatment for diabetes mellitus